In this study, we loaded the PFKFB3 small molecule inhibitor quercetin into cell membrane nanovesicles for the first time and validated its potential in AP treatment through a series of in vitro and in vivo experiments. The gene discussed is PFKFB3; the disease is alkaline phosphatase measurement.